Medicare Enrolled

Dr. Michael Lenihan, M.D.

Neurology · Glens Falls, NY
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
420 GLEN ST, Glens Falls, NY 12801
5187939155
In practice since 2006 (19 years)
NPI: 1285727792 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Lenihan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lenihan? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Lenihan

Dr. Michael Lenihan is a neurology specialist in Glens Falls, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Lenihan performed 7,277 Medicare services across 976 unique beneficiaries.

Between the years covered by Open Payments, Dr. Lenihan received a total of $58,475 from 45 pharmaceutical and/or device companies across 438 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Lenihan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 11% volume in NY $58,475 industry payments

Medicare Practice Summary

Medicare Utilization ↗
7,277
Medicare services
Top 11% in NY for neurology
976
Unique beneficiaries
$15
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~383 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Botox injection, per unit
An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered.
6,000 $1 $2
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
670 $81 $165
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
172 $109 $254
Ultrasound of head and neck blood flow, bilateral
An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck.
121 $25 $62
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
99 $44 $107
Electromyography of arm or leg muscles
A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them.
64 $69 $128
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
39 $118 $221
Awake and drowsy EEG
A test that records electrical activity in the brain while the patient is awake and drowsy.
25 $38 $86
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
23 $94 $215
New patient office visit, complex (60-74 min) 19 $164 $295
Nerve conduction studies, 5-6 tests
A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction.
17 $82 $210
Nerve conduction studies, 7-8 tests
A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles.
15 $116 $295
Nerve conduction study, 3-4 tests
A diagnostic test that measures how well nerves send electrical signals. It involves performing 3 to 4 separate nerve conduction studies to evaluate nerve function.
13 $62 $190
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$58,475
Total received (2018-2024)
Avg $8,354/year across 7 years
Top 10% in NY for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
45
Companies
438
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$26,546 (45.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$19,748 (33.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,181 (20.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$19,681
2023
$3,513
2022
$5,932
2021
$11,883
2020
$8,583
2019
$753
2018
$8,129

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Eisai Inc.
$15,127
UCB, Inc.
$3,415
EMD Serono, Inc.
$197
ABBVIE INC.
$186
Neurelis, Inc.
$172
SK Life Science, Inc.
$166
Amgen Inc.
$141
GENZYME CORPORATION
$125
Lilly USA, LLC
$66
ARGENX US, INC.
$37
Neurocrine Biosciences, Inc.
$28
PFIZER INC.
$21
Top 3 companies account for 95.2% of 2024 payments
All-time payments by company (2018-2024) ›
Eisai Inc.
$15,145
Biohaven Pharmaceuticals, Inc.
$9,902
Allergan, Inc.
$8,194
GENZYME CORPORATION
$5,333
ARGENX US, INC.
$4,201
LivaNova USA, Inc.
$4,110
UCB, Inc.
$3,601
Medtronic USA, Inc.
$1,389
ABBVIE INC.
$900
BANNER LIFE SCIENCES, LLC
$900
EMD Serono, Inc.
$734
Genentech USA, Inc.
$528
Novartis Pharmaceuticals Corporation
$498
Neurelis, Inc.
$386
Biogen, Inc.
$304
Amgen Inc.
$299
SK Life Science, Inc.
$269
Teva Pharmaceuticals USA, Inc.
$258
Alexion Pharmaceuticals, Inc.
$194
Lilly USA, LLC
$137
Supernus Pharmaceuticals, Inc.
$135
Neurocrine Biosciences, Inc.
$133
AbbVie Inc.
$131
Horizon Therapeutics plc
$124
SANOFI-AVENTIS U.S. LLC
$82
Janssen Pharmaceuticals, Inc
$77
Sunovion Pharmaceuticals Inc.
$70
PFIZER INC.
$62
Lundbeck LLC
$49
JAZZ PHARMACEUTICALS INC.
$36
Grifols USA, LLC
$33
Adamas Pharmaceuticals, Inc.
$30
Averitas Pharma Inc.
$26
TG THERAPEUTICS, INC.
$23
Alnylam Pharmaceuticals Inc.
$22
Acorda Therapeutics, Inc
$20
Bayer HealthCare Pharmaceuticals Inc.
$18
Upsher-Smith Laboratories LLC
$18
Kyowa Kirin, Inc.
$17
Impax Laboratories, Inc.
$17
GE Healthcare
$16
CSL Behring
$16
Allergan Inc.
$16
Avion Pharmaceuticals
$12
ARBOR PHARMACEUTICALS, INC.
$12
Top 3 companies account for 56.8% of all-time payments
Associated products mentioned in payments ›
ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · APTIOM · AUBAGIO · AUSTEDO · Aimovig · BAFIERTAM · BOTOX · BRIUMVI · Betaseron · Briviact · COPAXONE · Cenobamate · Dhivy · EMGALITY · Enspryng · GILENYA · GOCOVRI · Gamunex-C · Hizentra · Horizant · INGREZZA · KESIMPTA · KISUNLA · LATUDA · LEMTRADA · LIORESAL · LYRICA · Leqembi · MAVENCLAD · MAYZENT · Mavenclad · NURTEC ODT · Nourianz · OCREVUS · ONPATTRO · OXTELLAR XR · PAXLOVID · Ponvory · QELBREE · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUTENZA · RYTARY · Rebif · Rystiggo · SOLIRIS · SYNCHROMED · TECFIDERA · TROKENDI XR · TYSABRI · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS Therapy · VNS Therapy SenTiva Model 1000 Generator · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · XCOPRI · XYREM · Zilbrysq
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (45%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 10% for neurology in NY.

Looking for a neurology specialist in Glens Falls?
Compare neurologists in the Glens Falls area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
7
Per 100K population
10.7
County median income
$78,239
Nearest hospital
GLENS FALLS HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Lenihan is a mixed practice specialist, with above-average Medicare volume (top 11% in NY), with speaking/promotional industry engagement in the top 10% of NY peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Lenihan experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Lenihan performed 6,000 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lenihan receive payments from pharmaceutical companies?
Yes. Dr. Lenihan received a total of $58,475 from 45 companies across 438 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lenihan's costs compare to other neurologists in Glens Falls?
Dr. Lenihan's average Medicare payment per service is $15. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lenihan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →